TABLE 2.
Top-ranked targets for medication adherence management over the next 20 years.
| Social and economic dimension |
|---|
| • Implementation of comprehensive measures of medication adherence, establishing a stronger connection between adherence metrics and health outcomes |
| • Thorough examination of the financial implications of medication adherence |
| Therapy dimension |
|---|
| • Advancing the role of digital technology in improving adherence |
| • Appropriate management of adherence in the context of polypharmacy and multimorbidity |
| Patient dimension |
|---|
| • Provision of patient education to enhance their understanding of their illness and medications |
| • Incorporation of medication adherence as a standard measure in routine clinical practice |
| Condition dimension |
|---|
| • Implementation of new technologies to support adherence and persistence, directly targeting pathogenic mechanisms contributing to disease development |
| • Improved identification of patients at high risk of non-adherence in clinical practice |
| Healthcare system dimension |
|---|
| • Using artificial intelligence in medication adherence management |
| • Increased access to adherence-enhancing interventions through the expansion of reimbursement and insurance coverage |